000 | 01216 a2200337 4500 | ||
---|---|---|---|
005 | 20250513192024.0 | ||
264 | 0 | _c19991004 | |
008 | 199910s 0 0 eng d | ||
022 | _a1527-9995 | ||
024 | 7 |
_a10.1016/s0090-4295(99)00259-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGleason, D M | |
245 | 0 | 0 |
_aEvaluation of a new once-daily formulation of oxbutynin for the treatment of urinary urge incontinence. Ditropan XL Study Group. _h[electronic resource] |
260 |
_bUrology _cSep 1999 |
||
300 |
_a420-3 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aCholinergic Antagonists _xadministration & dosage |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMandelic Acids _xadministration & dosage |
650 | 0 | 4 |
_aUrinary Incontinence _xdrug therapy |
700 | 1 | _aSusset, J | |
700 | 1 | _aWhite, C | |
700 | 1 | _aMunoz, D R | |
700 | 1 | _aSand, P K | |
773 | 0 |
_tUrology _gvol. 54 _gno. 3 _gp. 420-3 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0090-4295(99)00259-9 _zAvailable from publisher's website |
999 |
_c10432786 _d10432786 |